Cargando…
Pseudopeptide Amyloid Aggregation Inhibitors: In Silico, Single Molecule and Cell Viability Studies
Neurodegeneration in Alzheimer’s disease (AD) is defined by pathology featuring amyloid-β (Aβ) deposition in the brain. Aβ monomers themselves are generally considered to be nontoxic, but misfold into β-sheets and aggregate to form neurotoxic oligomers. One suggested strategy to treat AD is to preve...
Autores principales: | Robinson, Morgan, Lou, Jennifer, Mehrazma, Banafsheh, Rauk, Arvi, Beazely, Michael, Leonenko, Zoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865305/ https://www.ncbi.nlm.nih.gov/pubmed/33494369 http://dx.doi.org/10.3390/ijms22031051 |
Ejemplares similares
-
d-Amino Acid Pseudopeptides as Potential Amyloid-Beta Aggregation Inhibitors
por: Mehrazma, Banafsheh, et al.
Publicado: (2018) -
Effect of Metals on Kinetic Pathways of Amyloid-β Aggregation
por: Hane, Francis, et al.
Publicado: (2014) -
On the Involvement of Copper Binding to the N-Terminus of the Amyloid Beta Peptide of Alzheimer's Disease: A Computational Study on Model Systems
por: Azimi, Samira, et al.
Publicado: (2011) -
Orbital interaction theory of organic chemistry
por: Rauk, Arvi 1942-
Publicado: (2001) -
Orbital interaction theory of organic chemistry
por: Rauk, Arvi 1942-
Publicado: (1994)